on Jaguar Health, Inc. (NASDAQ:JAGX)
Jaguar Health, Inc. Schedules Investor Webcast for Q4 2023 Financial Review and Updates
Jaguar Health, Inc. (NASDAQ:JAGX) is inviting investors to a webcast scheduled for April 1, 2024, at 8:30 AM Eastern Standard Time. This event aims to discuss the company's financial performance for the fourth quarter of 2023 and provide corporate updates. The company has also announced plans to file its annual earnings report on the same day.
The webcast will offer a platform for attendees to gain insights directly from the leadership of Jaguar Health regarding the company’s latest financial outcomes and strategic maneuvers. Those interested in joining the webcast are required to register through a provided link.
Jaguar Health, a pharmaceutical company headquartered in San Francisco, CA, focuses on developing proprietary medicines derived from rainforest plants for people and animals experiencing gastrointestinal distress. It operates several subsidiaries, including Napo Pharmaceuticals and Napo Therapeutics in Europe, and has partnerships aimed at developing medicines for mental health and gastrointestinal symptoms.
R. P.
Copyright © 2024 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all Jaguar Health, Inc. news